17 July 2024 in Nature Communications
Meconium, a non-invasive biomaterial reflecting prenatal substance accumulation, could provide valuable insights into neonatal health. However, the comprehensive protein profile of meconium across gestational ages remains unclear. Here, we conducted an extensive proteomic analysis of first meconium from 259 newborns across varied gestational ages to delineate protein composition and elucidate its relevance to neonatal diseases. The first meconium samples were collected, with the majority obtained before feeding, and the mean time for the first meconium passage from the anus was 11.9 ± 9.47 h. Our analysis revealed 5370 host-derived meconium proteins, which varied depending on sex and gestational age. Specifically, meconium from preterm infants exhibited elevated concentrations of proteins associated with the extracellular matrix. Additionally, the protein profiles of meconium also exhibited unique variations depending on both specific diseases, including gastrointestinal diseases, congenital heart diseases, and maternal conditions. Furthermore, we developed a machine learning model to predict gestational ages using meconium proteins. Our model suggests that newborns with gastrointestinal diseases and congenital heart diseases may have immature gastrointestinal systems. These findings highlight the intricate relationship between clinical parameters and meconium protein composition, offering potential for a novel approach to assess neonatal gastrointestinal health.
25 October 2025 in Pediatrics & Neonatology
Very-low-birth-weight infants (VLBWIs) are at risk of extrauterine growth restriction (EUGR), which is associated with poor neurodevelopmental outcomes. This study aimed to determine the incidence of EUGR in VLBWIs and the factors associated with EUGR using a longitudinal definition. Data of infants with birth weights <1500 g admitted to a university hospital in Tokyo were collected from medical records. Longitudinal EUGR was defined as a loss of weight and head circumference exceeding one standard deviation score between birth and 36 weeks of postmenstrual age. In total, 334 VLBWIs participated in this study. Longitudinal EUGR incidence for weight and head circumference were 31.4 % and 38.3 %, respectively. In the multivariate analysis, significant risk factors for longitudinal EUGR based on weight and head circumference were congenital heart disease and a greater number of days to reach 150 ml/kg/day by enteral feeding. This study was the first to demonstrate that congenital heart disease was associated with EUGR using a longitudinal definition. Furthermore, the rate of increase in volume of enteral feeding was crucial for VLBWIs to maintain growth rates during hospitalization.
23 August 2023 in Pediatrics & Neonatology
Although neonatal disseminated intravascular coagulation (DIC) is associated with high mortality and severe complications, few studies have reported its clinical course. We aimed to describe the characteristics, treatments, and outcomes of neonatal DIC by using a national inpatient database. Using the Japanese Diagnosis Procedure Combination database, we identified 5533 patients with neonatal DIC who were admitted to neonatal intensive care units between July 2010 and March 2020. We categorized the patients into those with asphyxia (n = 2911) and those without asphyxia (n = 2622). We investigated the patient characteristics, treatments, and outcomes. We further categorized neonates with asphyxia according to its severity. The gestational age of neonates with asphyxia was significantly lower than that of neonates without asphyxia (P < 0.001). Antithrombin was most commonly used for DIC (40%). Neonates with asphyxia were more likely to receive antithrombin (43% vs. 38%; P < 0.001), recombinant human soluble thrombomodulin (28% vs. 20%; P < 0.001), and fresh frozen plasma transfusion (68% vs. 51%; P < 0.001) than those without asphyxia. Neonates with asphyxia had higher in-hospital mortality (17% vs. 10%; P < 0.001), severe bleeding (11% vs. 6.8%; P < 0.001), and hospitalization costs than those without asphyxia. Additionally, neonates with severe asphyxia were more likely to receive several DIC therapies (such as recombinant human soluble thrombomodulin [30% vs. 24%]) and had higher in-hospital mortality (19% vs. 11%) and hospitalization costs than those with mild asphyxia. In this large retrospective study of neonatal DIC, patients with asphyxia received several treatments and demonstrated unfavorable outcomes when compared to those without asphyxia.
1 January 2025 in Pediatrics International
25 June 2025 in Nature Communications
1 January 2026 in Congenital Anomalies